Provectus Biopharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $9.0M | $1.4M | $76.6K |
| FY2024 | $7.0M | $1.0M | $307.4K |
| FY2025 | $7.0M | $697.5K | $251.3K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $9.0M | $1.4M | $76.6K |
| FY2024 | $7.0M | $1.0M | $307.4K |
| FY2025 | $7.0M | $697.5K | $251.3K |